For IGF-1 LR3 specifically, the IGF-1 LR3 dosage calculator walks through the same math
While orforglipron has shown in studies to be slightly more effective at reducing body weight and reducing blood sugar levels than semaglutide, Orforglipron showed higher rates of adverse side effects such as nausea, vomiting and other gastrointestinal issues compared with semaglutide
This blend is widely used in laboratory and preclinical research as a model system to investigate synergistic effects on angiogenesis, actin regulation, cell migration, tissue regeneration, anti-inflammatory pathways, and overall wound healing responses in various in vitro and animal model systems
Badulescu S, Tabassum A, Le GH, Wong S, Phan L, Gill H, Llach CD, McIntyre RS, Rosenblat J, Mansur R (2024) Glucagon-like peptide 1 agonist and effects on reward behaviour: A systematic review
Semaglutide-related diarrhea tends to persist slightly longer during dose escalation, likely because the higher weight-loss dose takes longer to reach steady state